Page 1

Global Rare Disease Drugs MarketINDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2016–2024

© Coherent market Insights. All Rights Reserved


REPORT DESCRIPTION Global Rare Disease Drugs Market: Overview Rare diseases or orphan diseases are conditions that affect a small percentage of population at any given time. Orphan drug designation is given to the drugs indicated for the treatment of rare diseases. According to the U.S. Food & Drug Administration (FDA), an orphan disease is defined as a disease or condition affecting less than 200,000 people in the country. Orphan Drugs Act under the U.S. legislation allows manufacturer to request FDA to grant an orphan drug status to drugs intended to treat a rare disease or condition. According to the FDA, 2017, number of orphan drug designation requests have steadily increased over the past few years. The global rare disease drugs market was not considered lucrative until recently, owing to various uncertainties associated with these diseases. Small percentage of affected population provided limited opportunity for study. Moreover, diseases were poorly understood, owing to huge differentiation and heterogeneity among the group of diseases which discouraged manufacturers to address unmet needs in this space. Š Coherent market Insights. All Rights Reserved


REPORT DESCRIPTION Global Rare Disease Drugs Market : Growth Novartis AG is a global pharmaceutical organization with a diverse product folio ranging from drug therapies for cancer treatment to ophthalmic products. The company operates business through Innovative Medicines Division, which consists of oncology business unit and Novartis pharmaceutical business units. Innovative medicines Oncology division offers products for oncology diseases and rare diseases, and pharmaceutical business consists of ophthalmology, neuroscience, immunology and dermatology, respiratory, cardio-metabolic, and established medicines. Novartis lost patent protection for its orphan drug Gleevec for the treatment of chronic myeloid leukemia (CML) in 2015 and Sun Pharma brought out generic Gleevec in 2016 hampering the sales of Novartis for Gleevec.

Request Report Sample @ https://www.coherentmarketinsights.com/insight/request-sample/1200 Š Coherent market Insights. All Rights Reserved


REPORT DESCRIPTION Global Rare Disease Drugs Market : Key Players ● ● ● ● ● ● ● ● ● ●

Novartis AG Hoffmann-La Roche Ltd. Celgene Corporation Bristol-Myers Squibb Company Shire plc Pfizer, Inc. Sanofi S.A. Bayer Alexion Pharmaceuticals, Inc. Biogen, Inc.

Get More Details About This Report@ https://www.coherentmarketinsights.com/ongoing-insight/global-rare-diseasedrugs-market-competitive-analysis-1200 © Coherent market Insights. All Rights Reserved


ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.

SERVICES INDUSTRY ANALYSIS MARKET INTELLIGENCE SERVICES Š Coherent market Insights. All Rights Reserved

CUSTOMIZED RESEARCH CONSULT STUDIES

SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES


ABOUT CMI SECTOR COVERAGE

BIOTECHNOLOGY

CLINICAL DIAGNOSTIC

MEDICAL DEVICES

MEDICAL IMAGING

OUR CLIENTS        

Global Leading Equipment and System Manufacturers Component Providers and System Integrators Distributors, Retailors and Value Added Resellers Healthcare IT Solutions Developers Marketing Consultancies and the Advertising Industry Private and Government organization Outsourcing Companies Universities and Business Schools.

© Coherent market Insights. All Rights Reserved

HEALTHCARE IT

PHARMACEUTICAL


ABOUT COHERENT MARKET INSIGHTS

KEY STATS

RESEARCH SOLUTIONS

FEASIBILITY STUDIES

GLOBAL REPORTS

100+ Insights Published Per Year

150+ Consulting Projects Till Date

125+

COUNTRY ANALYSIS

CONSULT PROJECTS

SURVEY RESEAR CH

EXCEL FORECAST DATABASE COMPETITIVE ASSESSMENT

Clients Worldwide Per Year

110+

TECHNOLOGY SNIPPETS

Analysts and Contract Consultants

Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.

© Coherent market Insights. All Rights Reserved


THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 Š Coherent market Insights. All Rights Reserved

Profile for chaitanyag

Global rare disease drugs market  

Rare diseases or orphan diseases are conditions that affect a small percentage of population at any given time. Orphan drug designation is g...

Global rare disease drugs market  

Rare diseases or orphan diseases are conditions that affect a small percentage of population at any given time. Orphan drug designation is g...

Advertisement